Multiplexed Antibody Characterization - Combinatorial Evaluation of Species Cross-Reactivity Using a High Capacity Flow (HCF) Approach
6 Feb 2013

The discovery and development of antibody therapeutics is a time-intensive and costly process that involves screening of large candidate libraries, functional characterization of lead molecules in vitro, and preclinical testing in animal models of efficacy and toxicity. In this application note it is shown that the multiplexing capabilities of the IntelliCyt HTFC® Screening System, which utilizes a flow cytometry detection modality, can be used to incorporate cross species reactivity of antibodies into the screening phase of the discovery process. This assay enables high content studies to be performed in a high throughput setting.

Popular tags in SelectScience

Buying guides

Write a Review

Join the Global SelectScience Community Today! It’s FREE!

Helping you make informed decisions about the latest lab products and technologies:

  • Be the first to learn about new technologies
  • 10,000+ trusted product reviews from your peers
  • Compare 500,000 products and manufacturers
  • Get exclusive buying tips from experts
  • Find solutions fast: 10,000+ Application Notes, Webinars and Videos

Connect with 250,000 scientists... All in one place!

Become a member today!